IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The firm is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Mr. Patrick Mercer 2018 'den beri şirketle birlikte olan IRIDEX Corp 'in President 'ıdır.
IRIX hissesinin fiyat performansı nasıl?
IRIX 'in mevcut fiyatı $1.04 'dir, son işlem günde 1.92% arttırılmış etti.
IRIDEX Corp için ana iş temaları veya sektörler nelerdir?
IRIDEX Corp Health Care endüstrisine ait ve sektör Health Care 'dir
IRIDEX Corp 'in piyasa değerlemesi nedir?
IRIDEX Corp 'in mevcut piyasa değerlemesi $18.1M 'dir
IRIDEX Corp al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 3 analist IRIDEX Corp için analist derecelendirmeleri gerçekleştirdi, bunlar 0 güçlü al, 0 al, 3 tut, 1 sat ve 0 güçlü sat içermektedir